- Latest week
- 10 Jul 2026
- Close
- 80.379997
- Fair value
- 68.358427
- Next-week expectancy
- Undecided 47.02%
MRCK34 Chart Pack
Merck & Co., Inc.
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, MRCK34 rose 15.36%, moving from 69.68 to 80.38. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is 9.39 and has improved across the 12-week window. Market Dynamics is 0.43 on the latest week. Next-week expectancy is undecided at 47.02% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 80.38
- 12-Week Change
- 15.36%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 47.02%
- Signal Weeks
- 10 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 9.39
- Market Dynamics
- 0.43
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 80.38
- 12-Week Change
- 15.36%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 47.02%
- Signal Weeks
- 10 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 9.39
- Market Dynamics
- 0.43
Over the latest 12 completed weeks ending 2026-07-10, MRCK34 rose 15.36%, moving from 69.68 to 80.38. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is 9.39 and has improved across the 12-week window. Market Dynamics is 0.43 on the latest week. Next-week expectancy is undecided at 47.02% based on similar historical setup states.
Industry Peers
Brazil equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| PNVL3 Dimed S.A. Distribuidora de Medicamentos | SAO | 10 Jul 2026 | 10.77 | 11.45 | 10.43 | 11.30 | 4.92% |
| GILD34 Gilead Sciences, Inc. | SAO | 10 Jul 2026 | 331.92 | 349.20 | 330.78 | 332.38 | 0.14% |
| PFIZ34 Pfizer Inc. | SAO | 10 Jul 2026 | 31.35 | 31.42 | 30.45 | 31.17 | -0.57% |
| G1SK34 GSK plc | SAO | 10 Jul 2026 | 55.44 | 55.86 | 54.84 | 55.05 | -0.70% |
| AMGN34 Amgen Inc. | SAO | 10 Jul 2026 | 67.25 | 67.62 | 66.05 | 66.18 | -1.59% |
| LILY34 Eli Lilly and Company | SAO | 10 Jul 2026 | 209.50 | 214.47 | 201.21 | 202.55 | -3.32% |
| JNJB34 Johnson & Johnson | SAO | 10 Jul 2026 | 90.59 | 92.41 | 86.90 | 87.40 | -3.52% |
| N1VS34 Novartis AG | SAO | 10 Jul 2026 | 81.92 | 81.92 | 78.72 | 78.72 | -3.91% |
| N1VO34 Novo Nordisk A/S | SAO | 10 Jul 2026 | 33.00 | 33.00 | 30.86 | 31.62 | -4.18% |
| BIIB34 Biogen Inc. | SAO | 10 Jul 2026 | 181.70 | 181.70 | 170.34 | 170.34 | -6.25% |
| ABBV34 AbbVie Inc. | SAO | 10 Jul 2026 | 85.49 | 85.49 | 77.92 | 78.96 | -7.64% |
| A1ZN34 AstraZeneca PLC | SAO | 10 Jul 2026 | 164.21 | 165.99 | 146.25 | 146.50 | -10.78% |